Industry news

$1.4M grant supporting development of foam with military, civilian applications for trauma care

U.S. Secretary of Agriculture Sonny Perdue today issued a statement providing clarification on the U.S. Department of Agriculture’s (USDA) oversight of plants produced through innovative new breeding techniques which include techniques called genome editing.

The device that was developed last year to provide wireless measurement of vital signs such as respiration and heartbeat has been downsized and further advanced.

Pancreatic cancer has one of the worst prognoses — with a five-year survival rate of 9 percent — in part because there are no telltale symptoms or non-invasive screening tools to catch a tumor before it spreads.

World's first car to be fuelled by whisky residue biofuel takes its inaugural journey

According to the report, global anti-aging market was valued at USD 140.3 billion in 2015, is expected to reach USD 216.52 billion in 2021 and is anticipated to grow at a CAGR of 7.5% between 2016 and 2021.

Rituximab is a monoclonal antibody to the CD20 protein, approved for the treatment of non-Hodgkin's lymphoma and B-cell chronic lymphocytic leukemia, as well as other diseases characterized by excessive, overactive or dysfunctional B cells.

Semiotic, a Russian developer and manufacturer of microchips for blood tests, and Yashraj Biotechnology Ltd., one of the Top-20 in India’s pharmaceutical market, have inked an agreement that opens India’s doors to Semiotic’s carbohydrate microchip, aka glycochip, which is said to be able to quantify glycan-bonding proteins, announced the website of RVC, Russia’s fund of funds for innovation. Semiotic is a portfolio company of the RVC Biofund, the investment arm to support biomed and biotech projects.